glp-1 shortage news today november 2025 Weight Loss Drug Enforcement in 2025: State Attorneys General Step into a Growing Regulatory Gap Generic GLP-1 medications: Current and

There are actually a number of them that can cause weight gain

In some supervised clinical contexts, yes

In a case involving toxic exposure, Equity Partner Patrick A

Other at-risk populations include individuals on chronic steroids, which cause muscle wasting, patients unable to engage in strength and resistance training, or patients with muscle-wasting conditions like chronic kidney disease. McGowan also noted that even healthy individuals should expect some muscle loss

In this regard, DPP-4 resistant GLP-1 analogues including exenatide, liraglutide, albiglutide, dulaglutide are FDA approved and these analogues exhibit increased half-life

Constipation is a common side effect of GLP-1 medications like Ozempic and Wegovy